During the COVID-19 pandemic, as an emergency, fast-track guideline development, based on the order of the Minister of Health dated March 27, 2020, Agency published the first version of the Recommendations in COVID-19, prepared in collaboration with an interdisciplinary Team of Clinical Experts (from: anesthesiology and intensive care, infectious diseases, laboratory diagnostics, epidemiology, microbiology, virology, pulmonology, radiology, psychiatry and emergency medicine), coordinated by the Steering Committee, composed of the Presidium of the Transparency Council of the Agency for Health Technology Assessment and Tarification.
In view of the rapidly changing pandemic situation and the continuous influx of new scientific evidence for the clinical efficacy and safety of medical technologies used in COVID-19, the Agency is conducting a continuous process of updating the Recommendations. The current sets of recommendations for diagnosis, pharmacotherapy, and long COVID/post-COVID can be found under the tabs:
Due to the declining epidemic threat of COVID-19, recommendations for diagnostic management have been developed.
- Recommendations in Covid
- COVID-19 Publication Radar
- IHME COVID-19 Forecasts
- PUBLICATION DATABASE
- Review of international guidelines in COVID-19
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out .
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]